Cargando…
Ubiquitin-specific protease 12 interacting partners Uaf-1 and WDR20 are potential therapeutic targets in prostate cancer
The androgen receptor (AR) is a key transcription factor in the initiation and progression of prostate cancer (PC) and is a major therapeutic target for the treatment of advanced disease. Unfortunately, current therapies are not curative for castration resistant PC and a better understanding of AR r...
Autores principales: | McClurg, Urszula L., Harle, Victoria J., Nabbi, Arash, Batalha-Pereira, Amanda, Walker, Scott, Coffey, Kelly, Gaughan, Luke, McCracken, Stuart RC, Robson, Craig N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741960/ https://www.ncbi.nlm.nih.gov/pubmed/26462181 |
Ejemplares similares
-
Deubiquitinating enzyme Usp12 regulates the interaction between the androgen receptor and the Akt pathway
por: McClurg, Urszula L., et al.
Publicado: (2014) -
Human ex vivo prostate tissue model system identifies ING3 as an oncoprotein
por: McClurg, Urszula L, et al.
Publicado: (2018) -
Identification of a novel K311 ubiquitination site critical for androgen receptor transcriptional activity
por: McClurg, Urszula L., et al.
Publicado: (2017) -
ING3 promotes prostate cancer growth by activating the androgen receptor
por: Nabbi, Arash, et al.
Publicado: (2017) -
Deubiquitinating enzymes as oncotargets
por: McClurg, Urszula L., et al.
Publicado: (2015)